Hostname: page-component-848d4c4894-xfwgj Total loading time: 0 Render date: 2024-07-04T19:33:14.788Z Has data issue: false hasContentIssue false

Autoimmune limbic encephlitis. A rising differential diagnosis between diseases with psychiatric symptoms

Published online by Cambridge University Press:  23 March 2020

C. Martín Álvarez*
Affiliation:
Fuenlabrada Universitary Hospital, Fuenlabrada, Departament of Psychiatry, Fuenlabrada, Spain
F. Cadenas Extremera
Affiliation:
Fuenlabrada Universitary Hospital, Fuenlabrada, Departament of Psychiatry, Fuenlabrada, Spain
V. Alonso García
Affiliation:
Fuenlabrada Universitary Hospital, Fuenlabrada, Departament of Psychiatry, Fuenlabrada, Spain
M. del Valle Loarte
Affiliation:
Fuenlabrada Universitary Hospital, Fuenlabrada, Department of Neurology, Fuenlabrada, Spain
M. Bravo Arraez
Affiliation:
José Germain Psychiatric Institute, Departament of Psychiatry, Leganes, Spain
V. Mainar de Paz
Affiliation:
José Germain Psychiatric Institute, Departament of Psychiatry, Leganes, Spain
*
* Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

In psychiatric clinical practice, we can face numerous organic diseases in the differential diagnosis between primary psychiatric disorders. As an example of this, we can see the autoimmune limbic encephalitis(LE), which in a significant percentage of cases begins with psychiatric symptoms. Currently, one of the theories of the origin of the LE is as a idiopathic autoimmune entity, leaving behind the idea of been generated only by a viral or paraneoplastic etiology.

Objective

To achieve a better knowledge about this underdiagnosed entity, presenting a case of an anti-LGI1 limbic encephalitis.

Case

A 60-year-old Caucasian woman who starts with neuropsychiatric symptoms as: behavioral disorders, manic symptoms, memory impairment and attention deficit.

Results

Finally, the diagnosis was confirmed when the patient had positive results in both serum and CSF samples for anti-LGI1 antibodies. Gastric neuroendocrino tumour type I was discovered. Neither paraneoplasic syndrome nor onconeuronal antibodies were shown. A thin hyperintense signal was identified in the left hippocampus using a brain MRI. Despite the patient had been treated with corticosteroids, immunosuppressants and immunoglobulins, she still showed positive antibodies in CSF samples with poor clinical results, especially psychiatric symptoms. The patient required one psychiatric hospitalization due to reference and persecutory delusions and manic symptoms.

Conclusion

Our patient had an unsatisfactory evolution with little response to immune treatment. Given the possible underdiagnosis of this condition, the importance of a differential diagnosis and an early treatment, we consider that there is an important need for a greater knowledge and scientific divulgation of this clinical entity.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
EV1407
Copyright
Copyright © European Psychiatric Association 2016
Submit a response

Comments

No Comments have been published for this article.